Call for expression of interest to join the UHC2030 Private Sector Constituency

UHC2030 is a multi-stakeholder partnership

UHC2030 is a multi-stakeholder partnership for advocacy, accountability and coordination of health systems strengthening efforts to accelerate progress towards UHC. UHC2030 is guided by the principles set out in the UHC2030 Global Compact. As a multi-stakeholder partnership, UHC2030 includes governments, international organisations, civil society organisations, the private sector, academia, and media (more information here). 

Universal Health Coverage requires a coordinated effort by all partners

Universal health coverage (UHC) is based on the principle that all individuals and communities should have equitable access to quality essential health services without suffering financial hardship. 

UHC2030 partners recognize that achieving UHC will require coordinated efforts by all stakeholders across multiple sectors. To reach UHC by 2030 the partnership specifically recognizes the importance of engaging the private sector given its important role in health care, not only in high-income, but particularly in low- and middle-income countries. 

Bringing together private sector entities working towards UHC

To ensure that the private sector is represented in the joint movement towards UHC, private sector entities working towards UHC are invited to join the UHC2030 Private Sector Constituency. 

The UHC2030 Private Sector Constituency will be the convening platform for private sector entities who wish to contribute to exchange on and collaborate towards UHC. The constituency will foster dialogue, convene and collaborate with private sector actors and provide a platform for interaction with the private sector for all UHC2030’s partners and health systems networks.

What does it mean to become a member of the UHC2030 Private Sector Constituency?

As part of the UHC2030 Private Sector Constituency, your entity will be able to engage in the global dialogue on UHC and engage with UHC2030 and its partners on health system strengthening for UHC. The constituency has two levels of membership: 

  1. The Consultative Group
  2. The Core Action Group 

Every entity that fulfils the criteria below will automatically be part of the Consultative Group of the Private Sector Constituency. The Consultative Group will represent a broad range of private sector perspectives and contributes to the global dialogue on UHC through consultations carried out by the Core Action Group. Members of the Consultative Group will receive news and information about the group’s activities and will be invited to join meetings and conferences that are relevant to their expertise by UHC2030 and its partners. 

Entities that are particularly committed and interested to participate in the global dialogue on UHC can apply to be part of the Core Action Group

The role of the Core Action Group will be to bring in the perspectives of the private sector to the UHC2030 platform and as such, its members will need to actively engage with UHC2030 and its partners - including WHO, the World Bank and related health systems networks. Members of the Core Action Group will be invited to participate in hearings and consultation related to UHC2030’s work on advocacy, accountability, knowledge management and health systems strengthening coordination for UHC. The Core Action Group will also acts as the intermediary between UHC2030 and the Consultative Group. 

On formation, the Core Action Group will also develop the mandate, governance and funding arrangements for the UHC2030 Private Sector Constituency (more information here).

Who can join the UHC2030 Private Sector Constituency?

Applicants for membership must be for-profit private sector entities1 that are directly working on health system strengthening!

Applicants must:

  • Publicly commit to supporting the following UHC outcomes:
    1. Financial protection and 2. Access to quality health services for all.
  • Commit to engage in advocacy of, and promotion of the UHC2030 guiding principles of equity, quality, transparency and accountability.
  • Be willing to take part in open and honest dialogue about critical concerns and issues surrounding private sector engagement for health.
  • Ensure that their engagement adds value to public health and the UHC agenda.
  • Ensure that their reputation and activities do not compromise UHC2030’s objectivity, integrity, independence, and impartiality. 
  • Ensure that their participation in the UHC2030 Private Sector Constituency is not reflected as an endorsement of their views, or opinions and activities or grants any privilege or competitive advantage.
  • Ensure that they are not involved in any way with arms or tobacco industries, do not engage with the tobacco industry nor with non-State actors that work to further the interests of the tobacco industry and do not engage with the arms industry2

In addition, Core Action Group members must: 

  • Sign onto the UHC2030 Global Compact. 
  • Publish in their annual reports the specific ways that they are supporting the UHC2030 Global Compact.
  • Commit time and staff resources to the UHC2030 Private Sector Constituency.

UHC2030 will accept new members for its Private Sector Constituency every three months – the next deadline for application is 10 May 2019.

Register here

An overview of the information and documents to be provided by applicants to the constituency can be found here: Application Form Overview 

1. Definition used from Engagement with non-State actors (FENSA

2. In accordance with paragraphs 44 and 45 of the WHO Framework of engagement with non-State actors.

Current private sector constituency members

MEDx EHealthcenter, Netherlands

Royal Philips, Netherlands

Sanofi, France

Apollo Hospital, India

Organization of Pharmaceutical Producers of India, India

Merck, USA

Johnson Johnson, Belgium

Pfizer, USA

Japan Pharmaceutical Manufacturers Association, Japan

Henry Schein, USA

Novo Nordisk, Denmark

International Federation of Pharmaceutical Manufacturers and Associations, Switzerland

Kenya Association of Pharmaceutical Industry, Kenya

You are currently offline. Some pages or content may fail to load.